To study the effects of Hesperidin, flaxseed and both together in patients with metabolic syndrome, 100 patients will be randomly allocated to one of following four groups: control group, hesperidin group (2 capsules Hesperidin), flaxseed group (30 gram flaxseed) or flaxseed-hesperidin group (2 capsules Hesperidin and 30 gram flaxseed) for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, metabolic factors will be assessed and compared between groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
1000 mg hesperidin as two capsules
1000 mg hesperidin as two capsules and 30 grams flaxseed
30 grams flaxseed
no supplementation
National Nutrition and Food Technology Research Institute
Tehran, Iran (the Islamic Republic Of), Iran
RECRUITINGMetabolic syndrome: Number of participants with treated metabolic syndrome
Number of participants with treated metabolic syndrome
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.